Free Delivery Over $100
|
|
|||
|
||||
Overview"Japan is suffering from a ""device gap."" Compared to its American and European counterparts, Japan lags in adopting innovative medical devices and making new treatments and procedures available to its patients. Many blame its government and bureaucracy for Japan's delayed access to modern medicine and new medical devices. Christa Altenstetter examines the contextual social, historical, and political conditions of Japan's medical field to make sense of the state of the country's medical profession and its regulatory framework. She explores the development of regulatory frameworks and considers possibilities for eventual reform and modernization. More specifically, Altenstetter looks into how physicians and device companies connect to the government and bureaucracy, the relationships connecting Japanese patients to their medical system and governmental bureaucracy, and how the relationships between policymakers and the medical profession are changing. The issues addressed here are becoming increasingly relevant as numerous countries in Asia, Latin America, and Central and Eastern Europe are only now beginning to regulate medical technology, following the lead of the US and the European Union. Those interested in global medicine and Asian studies will find this book both informative and compelling." Full Product DetailsAuthor: Christa AltenstetterPublisher: Taylor & Francis Ltd Imprint: Routledge Weight: 0.453kg ISBN: 9781138512047ISBN 10: 1138512044 Pages: 219 Publication Date: 06 October 2017 Audience: College/higher education , General/trade , Tertiary & Higher Education , General Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsList of Tables Acknowledgments Abbreviations 1 Introduction 2 Knowledge, Analyses, and Experiences 3 Medical Technology Regulation 4 The Pharmaceutical Affairs Law (PAL) 5 Responses to Global Pressures 6 Organizational Reform and Government Responsibilities 7 Advisory Committees, Science, and Reimbursement 8 Initiatives, Operations, and Processes 9 Realities of Clinical Medicine Summary and Concluding Comments Bibliography IndexReviewsAuthor InformationChrista Altenstetter Tab Content 6Author Website:Countries AvailableAll regions |
||||
